Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)
| Autor: | Saura, C., Modi, S., Krop, I., Park, Y.H., Kim, S.-B., Tamura, K., Iwata, H., Tsurutani, J., Sohn, J., Mathias, E., Liu, Y., Cathcart, J., Singh, J., Yamashita, T. |
|---|---|
| Zdroj: | In Annals of Oncology March 2024 35(3):302-307 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|